Laboratorios Senosiain
↗Mexico City, Mexico
Laboratorios Senosiain is a leading 100% Mexican pharmaceutical company dedicated to the development, manufacturing, and commercialization of high-quality pharmaceutical products. Founded in 1928, it has established itself as a leader in the private pharmaceutical sector in Mexico, focusing on both branded generics and innovative formulations.
The company operates multiple manufacturing facilities, including a major plant in Celaya, Guanajuato, which is FDA-inspected. Senosiain has a diverse portfolio covering therapeutic areas such as Gastroenterology, Respiratory, Central Nervous System (CNS), Cardiovascular, and Oncology. They are known for their commitment to innovation and quality, maintaining a strong presence in the Mexican market and expanding into other Latin American countries.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Branded Generics & Specialty Pharma
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$500M
Founded:1928
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Modified release, Topical/Gels, Injectables
Active Trials:5
Trial Phases:Phase 2: 1 | Phase 3: 2 | Phase 4: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Senosiain USA (Export/Distribution), OTC Senosiain
Key Partnerships:UNAM (Academic/Research), Various Latin American distributors
COMPETITION
Position:Leader
Competitors:Laboratorios Silanes, Genomma Lab, Liomont, Chinoin, Sanfer
LEADERSHIP
Key Executives:
Hector Senosiain Aguilar - CEO
Carlos Senosiain Aguilar - President & Director General
Juan Pablo Senosiain - Technical Director
Scientific Founders:Francisco Senosiain
Board Members:Hector Senosiain Aguilar, Carlos Senosiain Aguilar
LINKS
Website:senosiain.com.mx
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Laboratorios Senosiain. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.